4//SEC Filing
Landsittel Michael 4
Accession 0001415889-24-012843
CIK 0001597264other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:05 PM ET
Size
18.5 KB
Accession
0001415889-24-012843
Insider Transaction Report
Form 4
Landsittel Michael
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-05-08$8.80/sh+1,818$15,998→ 75,467 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-08+26,363→ 0 totalExercise: $1.87Exp: 2025-02-10→ Common Stock (26,363 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-08+1,818→ 0 totalExercise: $8.80Exp: 2024-10-08→ Common Stock (1,818 underlying) - Exercise/Conversion
Common Stock
2024-05-08$1.87/sh+26,363$49,299→ 73,649 total
Footnotes (3)
- [F1]This transaction involved a cash exercise of options without a subsequent sale of the underlying shares of common stock.
- [F2]The options were granted on February 10, 2015 and are fully vested as of the transaction date.
- [F3]The options were granted on October 8, 2014 and are fully vested as of the transaction date.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001651036
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 4:05 PM ET
- Size
- 18.5 KB